APA-referens

Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004). The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. National Academy of Sciences.

Chicago-stil citat

Lynch, Berkley A., Nathalie Lambeng, Karl Nocka, Patricia Kensel-Hammes, Sandra M. Bajjalieh, Alain Matagne, och Bruno Fuks. The Synaptic Vesicle Protein SV2A Is the Binding Site for the Antiepileptic Drug Levetiracetam. National Academy of Sciences, 2004.

MLA-referens

Lynch, Berkley A., et al. The Synaptic Vesicle Protein SV2A Is the Binding Site for the Antiepileptic Drug Levetiracetam. National Academy of Sciences, 2004.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.